Random small interfering RNA library screen identifies siRNAs that induce human erythroleukemia cell differentiation

References

• Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006;355:1253–1261.
   PubMed Web of Science ®Google Scholar
• Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 2001;90:105–156.
   PubMed Web of Science ®Google Scholar
• Zhang D, Cho E, Wong J. A critical role for the co-repressor N-CoR in erythroid differentiation and heme synthesis. Cell Res 2007;17:804–814.
   PubMed Web of Science ®Google Scholar
• Wolter F, Stein J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr 2002;132:2082–2086.
   PubMed Web of Science ®Google Scholar
• Zochodne B, Truong AHL, Stetler K, et al. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia. Oncogene 2000;19:2296–2304.
   PubMed Web of Science ®Google Scholar
• Song J, Lu YC, Yokoyama K, Rossi J, Chiu R. Cyclophilin A is required for retinoic acid-induced neuronal differentiation in p19 cells. J Biol Chem 2004;279:24414–24419.
   PubMed Web of Science ®Google Scholar
• Massard C, Deutsch E, Soria JC. Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 2006;17:1620–1624.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494–498.
   PubMed Web of Science ®Google Scholar
• Dutkiewicz M, Grunert HP, Zeichhardt H, Lena SW, Wengel J, Kurreck J. Design of LNA-modified siRNAs against the highly structured 5′ UTR of coxsackievirus B3. FEBS Lett 2008;582:3061–3066.
   PubMed Web of Science ®Google Scholar
• Snygg AS, Elmroth SK. Expanding the chemical nature of siRNAs: oxaliplatin as metalation reagent. Biochem Biophys Res Commun 2009;379:186–190.
   PubMed Web of Science ®Google Scholar
• Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 2009;28:1708–1719.
   PubMed Web of Science ®Google Scholar
• Pushparaj PN, Aarthi JJ, Kumar SD, Manikandan J. RNAi and RNAa–the yin and yang of RNAome. Bioinformation 2008;2:235–237.
   PubMedGoogle Scholar
• Zhang J, Mendoza M, Guiraldelli MF, Barbu EA, Siraganian RP. Small interfering RNA screen for phosphatases involved in IgE-mediated mast cell degranulation. J Immunol 2010;184:7178–7185.
   PubMed Web of Science ®Google Scholar
• Poleshko A, Einarson MB, Shalginskikh N, et al. Identification of a functional network of human epigenetic silencing factors. J Biol Chem 2010;285:422–433.
   PubMed Web of Science ®Google Scholar
• Paulsen RD, Soni DV, Wollman R, et al. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol Cell 2009;35:228–239.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhang L, Zhang HY, et al. A universal plasmid library encoding all permutations of small interfering RNA. Proc Natl Acad Sci USA 2005;102:2356–2361.
   PubMed Web of Science ®Google Scholar
• Kaykas A, Moon RT. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells. BMC Cell Biol 2004;30:16.
   Web of Science ®Google Scholar
• Sioud M, Walchli S. Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs. Methods Mol Biol 2005;309:83–91.
   PubMedGoogle Scholar
• Wang Y, Wang YE, Cotticelli MG, Wilson RB. A random shRNA-encoding library for phenotypic selection and hit-optimization. PLoS One 2008;3:e3171.
   PubMed Web of Science ®Google Scholar
• Nichols M, Steinman RA. A recombinase-based palindrome generator capable of producing randomized shRNA libraries. J Biotechnol 2009;14:79–84.
   Web of Science ®Google Scholar
• Chasis JA, Mohandas N. Red blood cell glycophorins. Blood 1992;80:1869–1879.
   PubMed Web of Science ®Google Scholar
• Navarro F, Gutman D, Meire E, et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009;114:2181–2192.
   PubMed Web of Science ®Google Scholar
• Williams CA, Mondal D, Agrawal KC. The HIV-1 Tat protein enhances megakaryocytic commitment of K562 cells by facilitating CREB transcription factor coactivation by CBP. Exp Biol Med 2005;230:872–884.
   Web of Science ®Google Scholar
• Wen J, Huang S, Rogers H, Liliane A, Kohwi-Shigematsu T, Noguchi CT. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 2005;105:3330–3339.
   PubMed Web of Science ®Google Scholar
• Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci USA 2003;100:8811–8816.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Linsley PS. Recognizing and avoiding siRNA offtarget effects for target identification and therapeutic application. Nat Rev Drug Discov 2010;9:57–67.
   PubMed Web of Science ®Google Scholar
• Dahlgren C, Wahlestedt C, Thonberg H. No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNA. Biochem Biophys Res Commun 2006;341:1211–1217.
   PubMed Web of Science ®Google Scholar
• Maeda T, Shima Y, Sugiura S, Aizawa S, Tamai I. Changes of differentiation and proliferation in K562 cells with various levels of knockdown of cationic amino acid transporter. Drug Metab Pharmacokinet 2008;23:181–187.
   PubMed Web of Science ®Google Scholar
• Papetti M, Skoultchi AI. Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1. Mol Cancer Res 2007;5:1053–1062.
   PubMed Web of Science ®Google Scholar
• Blaybel R, Théoleyre O, Douablin A, Baklouti F. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival. Cell Res 2008;18:834–845.
   PubMed Web of Science ®Google Scholar
• Atar O, Levi BZ. PU.1 silencing leads to terminal differentiation of erythroleukemia cells. Biochem Biophys Res Commun 2005;329:1288–1292.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sugiura S, Kobayashi D, et al. Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene. Pharm Res 2007;24:1628–1635.
   PubMed Web of Science ®Google Scholar
• Brózik A, Casey NP, Hegedus C, et al. Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERK. Ann NY Acad Sci 2006;1090:344–354.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood 2009;113:775–783.
   PubMed Web of Science ®Google Scholar
• Cha MC, Lin A, Meckling KA. Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity. BMC Pharmacol 2005;2:7.
   Google Scholar
• Tomlinson DC, Lamont FR, Shnyder SD, Knowles MA. FGFR1 promotes proliferation and survival via activation of the MAPK pathway in bladder cancer. Cancer Res 2009;69:4613–4620.
   PubMed Web of Science ®Google Scholar
• Schulte JH, Lim S, Schramm A, et al. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 2009;6:2065–2071.
   Web of Science ®Google Scholar
• Ferrandiz N, Caraballo JM, Albajar M, et al. p21Cip1 confers resistance to imatinib in human chronic myeloid leukemia cells. Cancer Lett 2010;292:133–139.
   PubMed Web of Science ®Google Scholar
• Cuevas EP, Escribano O, Monserrat J, et al. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines. J Cell Biochem 2009;108:1292–1301.
   PubMed Web of Science ®Google Scholar
• Konwisorz A, Springwald A, Haselberger M, Goerse R, Ortmann O, Treeck O. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells. Endocr Relat Cancer 2010;17:147–157.
   PubMed Web of Science ®Google Scholar
• Duan Z, Ji D, Weinstein EJ, et al. Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett 2010;293:220–229.
   PubMed Web of Science ®Google Scholar
• Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008;321:956–960.
   PubMed Web of Science ®Google Scholar
• Rines DR, Gomez-Ferreria MA, Zhou Y, et al. Whole genome functional analysis identifies novel components required for mitotic spindle integrity in human cells. Genome Biol 2008;9:R44.
   PubMed Web of Science ®Google Scholar